Clamp, A. R., James, E. C., McNeish, I. A., Dean, A., Kim, J., O'Donnell, D. M., . . . Ledermann, J. A. (2019). Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): Primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. Lancet.
Styl ChicagoClamp, Andrew R., et al. "Weekly Dose-dense Chemotherapy in First-line Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Treatment (ICON8): Primary Progression Free Survival Analysis Results From a GCIG Phase 3 Randomised Controlled Trial." Lancet 2019.
Citace podle MLAClamp, Andrew R., et al. "Weekly Dose-dense Chemotherapy in First-line Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Treatment (ICON8): Primary Progression Free Survival Analysis Results From a GCIG Phase 3 Randomised Controlled Trial." Lancet 2019.